A systematic review of intracavernosal injection of mesenchymal stem cells for diabetic erectile dysfunction

  • Gampo Alam Irdam Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia https://orcid.org/0000-0001-6619-3659
  • Febriyani Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia https://orcid.org/0000-0002-8625-9472
  • Nur Rasyid Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Akmal Taher Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
DOI: https://doi.org/10.13181/mji.oa.204475
Keywords: diabetes mellitus, erectile dysfunction, mesenchymal stem cells
Abstract viewed: 1216 times
PDF downloaded: 699 times
HTML downloaded: 232 times
EPUB downloaded: 213 times

Abstract

BACKGROUND As current erectile dysfunction (ED) treatments are limited, other treatment such as stem cells should be explored. Hence, this study aimed to review the sources, method of administration, and therapeutic effect of mesenchymal stem cells (MSCs) for diabetic ED treatment.

METHODS All relevant articles regarding the use of MSCs for diabetic ED were searched in PubMed and Google Scholar databases from December 15, 2019 to January 1, 2020 published in the past 10 years. The keywords were “mesenchymal stem cells” and “diabetic ED”. The selection and critical appraisal of the studies were discussed. Diabetic ED was evaluated for functional and structural outcome. Functional outcome in animal studies was assessed by intracavernosal pressure/mean arterial pressure (ICP/MAP) ratio, meanwhile the structural outcome was done microscopically. In human study, the assessments were done using international index of erectile function score (IIEF-5) to erection hardness score and penile Doppler ultrasonography.

RESULTS There were 10 animal studies and 3 human studies. The studies used MSCs from adipose (n = 6), bone marrow (n = 4), placenta (n = 1), umbilical cord (n = 1), and muscle tissue (n = 1). The MSCs were administrated through intracavernosal injection in all studies. In all animal studies, functional outcome was improved, shown in higher ICP/MAP ratio. Microscopically, there were an increase of cavernosal endothelial cells, vascular endothelial growth factor, nitric oxide synthase, and smooth muscle cells. In human studies, IIEF-5 and erection hardness score were improved. Peak systolic velocity was also higher.

CONCLUSIONS MSCs may be a promising therapy for diabetic ED; however, long-term safety concerns still need further investigations.

Downloads

Download data is not yet available.

References

  1. Droller MJ, Anderson JR, Beck JC, Bremner WJ, Evans K, Gray M, et al. Impotence-NIH consensus development panel on impotence. JAMA. 1993;270(4):83-90. https://doi.org/10.1001/jama.270.1.83

  2. Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017;34(9):1185-92. https://doi.org/10.1111/dme.13403

  3. Maseroli E, Corona G, Rastrelli G, Lotti F, Cipriani S, Forti G et al. Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study. J Sex Med. 2015;12(4):956-65. https://doi.org/10.1111/jsm.12832

  4. Cholil AR, Lindarto D, Pemayun TG, Wisnu W, Kumala P, Puteri HH. DiabCare Asia 2012: diabetes management, control, and complications in patients with type 2 diabetes in Indonesia. Med J Indones. 2019;28(1):47-56. https://doi.org/10.13181/mji.v28i1.2931

  5. Hatzimouratidis K, Giuliano F, Moncada I, Munner A, Salonia A, Verze P, et al. EAU guidelines on erectile dysfunction, premature ejaculation, penile curvature, and priapism. 2019 [cited 2020 Apr 25]. Available from: https://uroweb.org/guideline/male-sexual-dysfunction/.

  6. Ismail EA, El-Sakka AI. Innovative trends and perspectives for erectile dysfunction treatment: a systematic review. Arab J Urol. 2016;14(2):84-93. https://doi.org/10.1016/j.aju.2016.04.002

  7. Vrijhof HJ, Delaere KP. Vacuum constriction devices in erectile dysfunction: acceptance and effectiveness in patients with impotence of organic or mixed aetiology. Br J Urol. 1994;74(1):102-5. https://doi.org/10.1111/j.1464-410X.1994.tb16555.x

  8. Dutta TC, Eid JF. Vacuum constriction devices for erectile dysfunction: a long-term, prospective study of patients with mild, moderate, and severe dysfunction. Urology 1999;54(5):891-3. https://doi.org/10.1016/S0090-4295(99)00264-2

  9. Yuan J, Hoang AN, Romero CA, Lin H, Dai Y, Wang R. Vacuum therapy in erectile dysfunction-science and clinical evidence. Int J Impot Res. 2010;22(4):211-9. https://doi.org/10.1038/ijir.2010.4

  10. Chung E. Stem cell therapy in diabetic men with erectile dysfunction: a step closer to safe and effective regenerative technology. Ann Trasnl Med. 2019;7(Suppl 1):S40. https://doi.org/10.21037/atm.2019.02.28

  11. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-5. https://doi.org/10.1080/14653240500319234

  12. Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191. https://doi.org/10.1042/BSR20150025

  13. Garcia MM, Fandel TM, Lin G, Shindel AW, Banie L, Lin CS, et al. Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med. 2010;7(1 Pt 1):89-98. https://doi.org/10.1111/j.1743-6109.2009.01541.x

  14. Qiu X, Lin H, Wang Y, Yu W, Chen Y, Wang R, et al. Intracavernous transplantation of bone marrow-derived mesenchymal stem cells restores erectile function of streptozocin-induced diabetic rats. J Sex Med. 2011;8(2):427-36. https://doi.org/10.1111/j.1743-6109.2010.02118.x

  15. Sun C, Lin H, Yu W, Li X, Chen Y, Qiu X, et al. Neurotrophic effect of bone marrow mesenchymal stem cells for erectile dysfunction in diabetic rats. Int J Androl. 2012;35(4):601-7. https://doi.org/10.1111/j.1365-2605.2012.01250.x

  16. Liu G, Sun X, Bian J, Wu R, Guan X, Ouyang B, et al. Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model. PLoS One. 2013;8(8):e72790. https://doi.org/10.1371/journal.pone.0072790

  17. He Y, He W, Qin G, Luo J, Xiao M. Transplantation KCNMA1 modified bone marrow-mesenchymal stem cell therapy for diabetes mellitus-induced erectile dysfunction. Andrologia. 2014;46(5):479-86. https://doi.org/10.1111/and.12104

  18. Liu T, Peng Y, Jia C, Fang X, Li J, Zhong W. Hepatocyte growth factor-modified adipose tissue-derived stem cells improve erectile function in streptozotocin-induced diabetic rats. Growth Factors. 2015;33(4):282-9. https://doi.org/10.3109/08977194.2015.1077825

  19. Kovanecz I, Vernet D, Masouminia M, Gelfand R, Loni L, Aboagye J, et al. Implanted muscle-derived stem cells ameliorate erectile dysfunction in a rat model of type 2 diabetes, but their repair capacity is impaired by their prior exposure to the diabetic milieu. J Sex Med. 2016;13(5):786-97. https://doi.org/10.1016/j.jsxm.2016.02.168

  20. Zhu LL, Zhang Z, Jiang HS, Chen H, Chen Y, Dai YT. Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction. Asian J Androl. 2017;19(4):425-32. https://doi.org/10.4103/1008-682X.179532

  21. Zhou F, Hui Y, Xu Y, Lei H, Yang B, Guan R, et al. Effects of adipose-derived stem cells plus insulin on erectile function in streptozotocin-induced diabetic rats. Int Urol Nephrol. 2016;48(5):657-69. https://doi.org/10.1007/s11255-016-1221-3

  22. Chen F, Zhang H, Wang Z, Ding W, Zeng Q, Liu W, et al. Adipose-derived stem cell-derived exosomes ameliorate erectile dysfunction in a rat model of type 2 diabetes. J Sex Med. 2017;14(9):1084-94. https://doi.org/10.1016/j.jsxm.2017.07.005

  23. Bahk JY, Jung JH, Han H, Min SK, Lee YS. Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transplant. 2010;8(2):150-60.

  24. Levy JA, Marchand M, Iorio L, Cassini W, Zahalsky MP. Determining the feasibility of managing erectile dysfunction in humans with placental-derived stem cells. J Am Osteopath Assoc. 2016;116(1):e1-5. https://doi.org/10.7556/jaoa.2016.007

  25. Al Demour SA, Jafar H, Adwan S, AlSharif A, Alhawari H, Alrabadi A, et al. Safety and potential therapeutic effect of two intracavernous autologous bone marrow derived mesenchymal stem cells injections in diabetic patients with erectile dysfunction: an open label phase I clinical trial. Urol Int. 2018;101(3):358-65. https://doi.org/10.1159/000492120

  26. Lin CS, Xin ZC, Wang Z, Deng C, Huang YC, Lin G, et al. Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev. 2012;21(3):343-51. https://doi.org/10.1089/scd.2011.0303

  27. Khera M, Albersen M, Mulhall JP. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015;12(5):1105-6. https://doi.org/10.1111/jsm.12871

  28. Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells. Gene Ther. 2002;9(10):642-7. https://doi.org/10.1038/sj.gt.3301719

  29. Lin CS. Advances in stem cell therapy for the lower urinary tract. World J Stem Cells. 2010;2(1):1-4. https://doi.org/10.4252/wjsc.v2.i1.1

  30. Reed-Maldonado A, Lue TF. The current status of stem-cell therapy in erectile dysfunction: a review. World J Mens Health. 2016;34(3):155-64. https://doi.org/10.5534/wjmh.2016.34.3.155

  31. Li M, Li H, Ruan Y, Wang T, Liu J. Stem cell therapy for diabetic erectile dysfunction in rats: a meta-analysis. PLoS One. 2016;11(4):e0154341. https://doi.org/10.1371/journal.pone.0154341

  32. Kim JH, Jo CH, Kim HR, Hwang YI. Comparison of immunological characteristics of mesenchymal stem cells from the periodontal ligament, umbilical cord, and adipose tissue. Stem Cells Int. 2018;2018:8429042. https://doi.org/10.1155/2018/8429042

  33. Hsieh JY, Fu YS, Chang SJ, Tsuang YH, Wang HW. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev. 2010;19(12):1895-910. https://doi.org/10.1089/scd.2009.0485

  34. Nagamura-Inoue T, He H. Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. World J Stem Cells. 2014;6(2):195-202. https://doi.org/10.4252/wjsc.v6.i2.195

  35. Haahr MK, Jensen CH, Toyserkani NM, Andersen DC, Damkier P, Sørensen JA, et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine. 2016;5:204-10. https://doi.org/10.1016/j.ebiom.2016.01.024

  36. Arima N, Nakamura F, Fukunaga A, Hirata H, Machida H, Kouno S, et al. Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study. Cytotherapy. 2010;12(2):265-8. https://doi.org/10.3109/14653240903390795

  37. Ryu JK, Kim DH, Song KM, Ryu DS, Kim SN, Shin DH, et al. Intracavernous delivery of clonal mesenchymal stem cells rescues erectile function in the streptozotocin-induced diabetic mouse. Andrology. 2016;4(1):172-84. https://doi.org/10.1111/andr.12138

  38. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726-36. https://doi.org/10.1038/nri2395

  39. Casiraghi F, Remuzzi G, Abbate M, Perico N. Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem Cell Rev Rep. 2013;9(1):65-79. https://doi.org/10.1007/s12015-011-9345-4

  40. Qiu X, Villalta J, Ferretti L, Fandel TM, Albersen M, Lin G, et al. Effects of intravenous injection of adipose-derived stem cells in a rat model of radiation therapy-induced erectile dysfunction. J Sex Med. 2012;9(7):1834-41. https://doi.org/10.1111/j.1743-6109.2012.02753.x

  41. Gokce A, Peak TC, Abdel-Mageed AB, Hellstrom WJ. Adipose tissue-derived stem cells for the treatment of erectile dysfunction. Curr Urol Rep. 2016;17(2):14. https://doi.org/10.1007/s11934-015-0569-8

  42. Lin CS, Ho HC, Chen KC, Lin G, Nunes LB, Lue TF. Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms. BJU Int. 2002;89(9):955-60. https://doi.org/10.1046/j.1464-410X.2002.02792.x

  43. Bochinski D, Lin GT, Nunes L, Carrion R, Rahman N, Lin CS, et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int. 2004;94(6):904-9. https://doi.org/10.1111/j.1464-410X.2003.05057.x

  44. Levy JA, Marchand M, Iorio L, Zribi G, Zahalsky MP. Effects of stem cell treatment in human patients with Peyronie disease. J Am Osteopath Assoc. 2015;115(10):e8-13. https://doi.org/10.7556/jaoa.2015.124

Published
2021-05-19
How to Cite
1.
Irdam GA, Febriyani, Rasyid N, Taher A. A systematic review of intracavernosal injection of mesenchymal stem cells for diabetic erectile dysfunction. Med J Indones [Internet]. 2021May19 [cited 2024Jul.3];30(2):96–105. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/4475
Issue
Vol. 30 No. 2 (2021): June
Section
Clinical Research

Copyright (c) 2021 Gampo Alam Irdam, Febriyani, Nur Rasyid, Akmal Taher

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.